CAMDEN NATIONAL CORP
For the period ended Mar 31, 2024. Filed May 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. RISK FACTORS
There are a number of factors that may adversely affect the Company’s business, financial results or stock price. Refer to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, for discussion of these risks.
(a) None
(b) None
(c) The Company's did not repurchase any of its stock during the three months ended March, 31, 2024:
| Issuer Purchases of Equity Securities | ||||
|---|---|---|---|---|
| Period | Totalnumber ofshares (or units)purchased | Averageprice paidper share (or unit) | Total number ofshares (or units) purchasedas part of publiclyannounced plans or programs | Maximum number (or appropriate dollar value) of shares (orunits) that may yet bepurchased under theplans or programs (1) |
| January 1-31, 2024 | — | $— | — | 750,000 |
| February 1-29, 2024 | — | — | — | 750,000 |
| March 1-31, 2024 | — | — | — | 750,000 |
| Total | — | $— | — | 750,000 |
(1) In January 2024, the Company announced that the Board of Directors had authorized a common stock repurchase program for management to repurchase up to 750,000 shares. This program replaced the 2023 repurchase program and will terminate upon the earlier of (i) reaching the authorized share repurchase amount, (ii) vote by the Board of Directors to terminate the plan, or (iii) January 5, 2025.
None.
Not applicable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.